摘要
恶性肿瘤是危害人类健康的最严重的疾病之一，并且其发病率在我国仍呈上升趋势。随着手术、化疗及放疗技术的发展，肿瘤患者的预后有了一定改善，但不可否认的是，即使是早期诊断、及时治疗，
出处
《人民军医》
2014年第3期326-327,共2页
People's Military Surgeon
参考文献18
-
1De Vita VT, Rosenberg SA. Two hundred years of cancer research [J]. New Engl J Med,2012,366(23):2207-2214.
-
2Amedei A,Niccolai E,D'Elios MM,et al. T cells and adoptive immu- notherapy:Recent developments and future prospects in gastrointesti- nal ontology[J]. Clin Dev Immunol,2011:320571.
-
3杨波,脱朝伟,张宁,刘秋珍.CIK细胞对人原发性胃恶性淋巴瘤生长及肝转移的抑制作用[J].解放军医学杂志,2007,32(11):1126-1129. 被引量：3
-
4Iwai K, Soejima K, Kudoh S, et al. Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer Results of a multicenter historical cohort study[J]. Cancer Ira-munol Immunother,2012,61(10) :781-790.
-
5Hunder NN,Wallen H,Cao J ,et al. Treatment of metastatic melano ma with autoiogous CD4+ T ceils against NY-ESO 1[J]. New Engl ] Med,2008,358(25) :2698-2703.
-
6Chu CS, Boyer J, Schullery DS, et al. Phase I/lI randomized trial of dendritic cell vaccination with or without cyclophosphamide for con- solidation therapy o{ advanced ovarian cancer in first or second remis- sion[J]. Cancer Imrnunol Immunother, 2012,61 (5) : 629 641.
-
7张军一,罗荣城,廖旺军,丁雪梅,李爱民.应用IL-2/TIL细胞治疗癌性胸(腹)腔积液187例[J].解放军医学杂志,2003,28(11):1007-1007. 被引量：1
-
8Dudley ME,Gross CA, Langhan MM,et al. CD8+ enriched "yang" tumor infiltrating lymphocytes can mediate regression o{ metastatic melanoma[J]. Clin Cancer Res, 2010,16(24) : 6122-6131.
-
9Hallett WH, Ames E, Alvarez M, et al. Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses[J]. Biol Blood Marrow Transplant, 2008, 14 (10) :1088-1099.
-
10Du X,Bai Z,Zhang J,et al. Prolonged survival of human hepatocari- noma ceils in the liver of newborn C57BL/6 mice and resulting cellu- lar xenorejection,especially the activation of hepatic natural killer T cells[J]. Pathobiology,2010,77(3) :115-128.
二级参考文献15
-
1Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量：83
-
2王欢,周芳坚,王其京,秦自科,黄丽惜,刘卓炜,韩辉,李永强,陈诗萍,夏建川.负载自体肿瘤细胞裂解物的DC疫苗联合CIK治疗晚期肾癌的临床观察——附10例报告[J].癌症,2006,25(5):625-630. 被引量：51
-
3赵明,吴沛宏,曾益新,夏建川,张福君,冼励坚,张毓平,周琨,范卫君,张亮,高飞,周启明.经肝动脉栓塞化疗序贯联合射频消融和细胞因子诱导的杀伤细胞治疗肝细胞癌的随机研究[J].中华医学杂志,2006,86(26):1823-1828. 被引量：53
-
4周启明,吴沛宏,赵明,王其京,黄丽惜,李永强,陈诗萍,夏建川.原发性肝癌经综合微创治疗后联合细胞因子诱导杀伤细胞灌注的近期疗效观察[J].癌症,2006,25(11):1414-1418. 被引量：31
-
5Clarke CA,Glaser SL.Changing incidence of non-Hodgkin lymphomas in the United States.Cancer,2002,94(7):2015.
-
6Koniaris LG,Drugas G,Katzman PJ,et al.Management of gastrointestinal lymphoma.J Am Coll Surg,2003,197(1):127.
-
7Krugmann J,Gschwendtner A,Mairinger T,et al.DNA ploidy in gastrointestinal B-cell lymphomas.An image analysis study of 43 cases.Anal Quant Cytol Histol,2003,25(1):31.
-
8Thalhammer S,Koehler U,Stark RW,et al.GTG banding pattern on human metaphase chromosomes reveaved by high resolution atomic-force microscopy.J Microsc,2001,202(Pt 3):464.
-
9Jaffe ES,Harris NL,Diebold J,et al.World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues.A progress report.Am J Clin Pathol,1999,111(1 Suppl 1):S8.
-
10Schmidt-Wolf IG,Lefterova P,Johnston V,et al.Propagation of large number of T cells with natural killer cell markers.Br J Haematol,1994,87(3):453.
共引文献3
-
1金颖,于晓娟,杨波,卢学春,朱宏丽,王晓媛.自体CIK细胞联合白介素-2治疗老年恶性血液病的疗效与护理[J].中华现代护理杂志,2010,16(4):406-407. 被引量：1
-
2李海燕,曹励民,王娟.三氧化二砷对人肝癌SMMC-7721细胞增殖、迁移及侵袭能力的影响[J].中国老年学杂志,2013,33(11):2572-2574. 被引量：15
-
3赵莉娜.细胞因子诱导的杀伤细胞治疗肿瘤研究现状[J].湖南中医杂志,2014,30(7):195-196.
同被引文献39
-
1钱其军,吴孟超.肿瘤精准细胞免疫治疗:梦想照进现实[J].中国肿瘤生物治疗杂志,2015,22(2):151-158. 被引量：28
-
2Wilson TR, Fridlyand J, YanY, et al. Widespread potentialfor growth-factor-driven resistance to anticancer kinase inhib-itors[J]. Nature,2012,487 : 505-509.
-
3Straussman R, Morikawa T,Shee K,et al. Tumour micro-environment elicits innate resistance to RAF inhibitorsthrough HGF secretion[J]. Nature. 2012,487 : 500-504.
-
4Crawford Y, Kasman I,Yu L,et al. PDGF-C mediates theangiogenic and tumorigenic properties of fibroblasts associatedwith tumors refractory to anti-VEGF treatment[J], CancerCell, 2009,15: 21-34.
-
5Yoshida T,IshiiG,Goto K,et al. Podoplanin-positive canc-er-associated fibroblasts in the tumor microenvironment in-duce primary resistance to EGFR-TKIs in lung adenocarcino-ma with EGFR mutation[J], Clin Cancer Res, 2015,21 : 642-651.
-
6Wang W1,Ma JL,Jia WD,et al. Periostin: a putative medi-ator involved in tumour resistance to anti-angiogenic therapy[J]? Cell Biol Int, 2011,35: 1085-1088.
-
7Catalano S,Giordano C,Panza S,et al. Tamoxifen throughGPER upregulates aromatase expression: a novel mechanismsustaining tamoxifen-resistant breast cancer cell growth[J].Breast Cancer Res Treat. 2014,146 : 273-285.
-
8Provenzano PP, Cuevas C,Chang AE,et al. Enzymatic tar-geting of the stroma ablates physical barriers to treatment ofpancreatic ductal adenocarcinoma[J], Cancer Cell, 2012,21:418-429.
-
9Schnegg Cl, Yang MH, Ghosh SK,et al. Induction of Vas-culogenic mimicry overrides VEGF-A silencing and enrichesstem-like cancer cells in melanoma [J]. Cancer Res, 2015,75: 1682-1690.
-
10Shi Y,Fax X,Deng H. et al. Trastuzumab triggers phago-cytic killing of high HER2 cancer cells in vitro and in vivo byinteraction with Fcr receptors on macrophages [J]. J Immu-nol, 2015, 194: 4379-4386.
引证文献3
-
1徐丹萍,林爱芬,颜卫华.靶向肿瘤微环境免疫治疗新进展[J].现代免疫学,2015,35(6):502-506. 被引量：2
-
2魏玺.肺癌患者输注CIK细胞的护理[J].内蒙古中医药,2016,35(6):150-150.
-
3赵雪玉,吴蓉,王军红.基于PubMed的肿瘤学研究热点与趋势聚类分析[J].人民军医,2017,60(9):866-869. 被引量：1
二级引证文献3
-
1沙子珺,唐仕欢,李志勇,杨滨,杨洪军.基于文本挖掘与分子对接技术的辣木叶功能定位研究[J].中国中药杂志,2020,45(2):331-340. 被引量：13
-
2陈凯,杨勋梅,纪华,陈宏.调强放疗对肿瘤微环境的影响[J].西南国防医药,2017,27(6):646-648.
-
3朱晶,马骉.老年结肠癌患者出院后口服抗肿瘤靶向药的依从性现状及影响因素[J].国际老年医学杂志,2024,45(2):183-186. 被引量：2
-
1杨海良.肿瘤过继性免疫治疗研究进展[J].国外医学（耳鼻咽喉科学分册）,1997,21(1):6-11. 被引量：1
-
2胡守友,王秀玲.白细胞介素II,LAK细胞过继性免疫治疗胃癌[J].中华消化杂志,1991,11(3):174-176. 被引量：1
-
3刁宏宇,潘德生,胡升,潘蔚然,王成林,赵崇智.应用肿瘤浸润淋巴细胞和IL-2治疗人脑胶质瘤15例报告[J].中国医科大学学报,1998,27(6):638-639.
-
4曾展伦,卢帆.妊娠合并结直肠癌13例报告[J].河北医学,2002,8(3):237-238. 被引量：3
-
5李丽,张鹏.过继性免疫化疗治疗恶性胸腔积液的疗效观察[J].第二军医大学学报,1994,15(1):93-94.
-
6于晓华,王益鑫.TIL辅助治疗肾细胞癌9例[J].医师进修杂志,1997,20(3):144-145.
-
7武爱文.肿瘤普查查什么?[J].抗癌之窗,2012(1):45-46.
-
8孙惠川.肝癌术后转移复发的治疗进展[J].癌症进展,2005,3(1):30-32. 被引量：5
-
9罗忠金,刘晶美,邱小华.TIL治疗消化道肿瘤伴癌性腹水的价值[J].江西医学院学报,2000,40(1):114-114.
-
10王颐,宋燕京,赵旭东,赵华洲,郗洪庆,蔡爱珍,陈凛.胃癌的过继性免疫治疗研究进展[J].现代生物医学进展,2017,17(10):1990-1993. 被引量：2
